| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,028,000 | 2,901,000 | 2,813,000 | 3,487,000 | | Cost of Revenue | 2,178,000 | 2,189,000 | 2,174,000 | 2,626,000 | | | Gross Profit | 850,000 | 712,000 | 639,000 | 861,000 | | | Operating Expenses | | Research Development | 99,000 | 95,000 | 98,000 | 100,000 | | Selling General and Administrative | 553,000 | 545,000 | 567,000 | 598,000 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 198,000 | 72,000 | (26,000) | 163,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 6,000 | (1,000) |
-
| 9,000 | | Earnings Before Interest And Taxes | 88,000 | 71,000 | (26,000) | 172,000 | | Interest Expense | (78,000) | 41,000 | 37,000 | 38,000 | | Income Before Tax | 166,000 | 30,000 | (63,000) | 134,000 | | Income Tax Expense | (28,000) | (1,000) | (11,000) | (29,000) | | Minority Interest |
-
| (2,000) | 2,000 |
-
| | | | Net Income From Continuing Ops | 194,000 | 29,000 | (50,000) | 163,000 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 193,000 | 29,000 | (50,000) | 163,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $193,000 | $29,000 | ($50,000) | $163,000 |
|
0.22% Nasdaq 0.00%
Income Statement
